Abemaciclib methanesulfonate 10 mg | 98.00%
TargetMol
LY2835219 is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM).
More Information Supplier PageAbemaciclib methanesulfonate
Search Results
Abemaciclib methanesulfonate 100 mg | 98.00%
TargetMol
LY2835219 is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM).
More Information Supplier PageAbemaciclib methanesulfonate
SW044248 25 mg | Purity Not Available
TargetMol
SW044248 is a noncanonical Top1 inhibitor. It has selective toxicity for NSCLC cells.
More Information Supplier PageSW044248
SW044248 50 mg | Purity Not Available
TargetMol
SW044248 is a noncanonical Top1 inhibitor. It has selective toxicity for NSCLC cells.
More Information Supplier PageSW044248
SW044248 5 mg | Purity Not Available
TargetMol
SW044248 is a noncanonical Top1 inhibitor. It has selective toxicity for NSCLC cells.
More Information Supplier PageSW044248
GSK6853 10 mg | Purity Not Available
TargetMol
GSK6853 is a potent, soluble, cell-active, and highly selective inhibitor of the BRPF1 bromodomain.
More Information Supplier PageGSK6853
GSK6853 100 mg | Purity Not Available
TargetMol
GSK6853 is a potent, soluble, cell-active, and highly selective inhibitor of the BRPF1 bromodomain.
More Information Supplier PageGSK6853
Carazolol 50 mg | 99.00%
TargetMol
Carazolol is a high-affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.
More Information Supplier PageCarazolol
Carazolol 100 mg | 99.00%
TargetMol
Carazolol is a high-affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.
More Information Supplier PageCarazolol
Methyl 13-cis-4-Oxoretinoate 5 mg | Purity Not Available
TargetMol
4-Keto 13-cis-Retinoic Acid is a retinoic acid metabolite in neuroblastoma.
More Information Supplier PageMethyl 13-cis-4-Oxoretinoate
